N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy
This nonrandomized clinical trial investigates the safety, tolerance, and therapeutic potential of N-acetylcysteine in lowering disease-associated biomarkers in patients with hereditary cystatin C amyloid angiopathy.